TY - JOUR
KW - COVID-19
KW - Community Health Services
KW - Counseling
KW - Humans
KW - Opioid-Related Disorders/drug therapy
KW - Pandemics
KW - Patient Participation
KW - Peer Group
KW - Telemedicine/methods
KW - Coronavirus
KW - Medications for opioid use disorder (MOUD)
KW - telehealth
AU - J. R. 2nd Langabeer
AU - A. Yatsco
AU - T. Champagne-Langabeer
A1 - 
AD - Houston Emergency Opioid Engagement System, The University of Texas Health Science Center, Houston, TX, United States of America. Electronic address: James.R.Langabeer@uth.tmc.edu.; Houston Emergency Opioid Engagement System, The University of Texas Health Science Center, Houston, TX, United States of America.; Houston Emergency Opioid Engagement System, The University of Texas Health Science Center, Houston, TX, United States of America.
BT - Journal of substance abuse treatment
C5 - Education & Workforce; Healthcare Policy; HIT & Telehealth; Opioids & Substance Use
DO - 10.1016/j.jsat.2020.108215
JF - Journal of substance abuse treatment
LA - eng
M1 - Journal Article
PB - Elsevier Inc
PY - 2021
SN - 1873-6483; 0740-5472; 0740-5472
SP - 108215
T1 - Telehealth sustains patient engagement in OUD treatment during COVID-19
T2 - Journal of substance abuse treatment
TI - Telehealth sustains patient engagement in OUD treatment during COVID-19
U1 - Education & Workforce; Healthcare Policy; HIT & Telehealth; Opioids & Substance Use
U2 - 33248863
U3 - 10.1016/j.jsat.2020.108215
VL - 122
VO - 1873-6483; 0740-5472; 0740-5472
Y1 - 2021
Y2 - Mar
ER -